Filing Details

Accession Number:
0001179110-18-003312
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-02 17:14:40
Reporting Period:
2018-02-28
Accepted Time:
2018-03-02 17:14:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1695686 J Joseph Manning 100 Abbott Park Road
Abbott Park IL 60064
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2018-02-28 9,520 $60.55 42,682 No 4 A Direct
Common Shares Without Par Value Disposition 2018-02-28 2,786 $60.55 39,896 No 4 F Direct
Common Shares Without Par Value Disposition 2018-03-01 1,430 $58.98 38,466 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 S Direct
Footnotes
  1. Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3.